Skip to main content
Log in

Association of metabolic factors with high-sensitivity C-reactive protein in patients with sleep-disordered breathing

  • Miscellaneous
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Sleep-disordered breathing (SDB) such as snoring or obstructive sleep apnea and metabolic syndrome are both related to cardiovascular diseases. Being a surrogate marker of high risk for cardiovascular disorder, the high-sensitivity C-reactive protein (hs-CRP) level is thought to be elevated in patients with both SDB and metabolic syndrome. To understand better the development of cardiovascular disease in patients with SDB, we examined the association of metabolic variables with hs-CRP levels in adult patients with symptoms of SDB and without any previous treatment, who were selected to participate in the study. Metabolic parameters including fasting blood glucose, lipid profile and hs-CRP were measured following an overnight polysomnography. Laboratory and polysomnographic data were analyzed to identify variables related to high hs-CRP levels. A total of 309 patients with SDB participated in this study. Of these, 139 presented with hs-CRP <1 mg/L and 52 presented with hs-CRP >3 mg/L. Patients with high hs-CRP showed a higher apnea-hypopnea index (AHI), body mass index (BMI), fasting glucose, and triglyceride level, and a lower mean and minimal oxygen saturation and HDL-cholesterol level. However, ordinal regression analysis demonstrated that only a higher BMI and fasting glucose level and a lower HDL-cholesterol level were independent risk factors for cardiovascular diseases (OR = 1.076, 95 % CI = 1.009–1.147, p = 0.005; OR = 1.011, 95 % CI = 1.004–1.019, p = 0.008; OR = 0.966, 95 % CI = 0.947–0.984, p < 0.001, respectively). The results showed that elevated hs-CRP is common in patients with SDB but is not independently associated with the severity of SDB. Metabolic factors such as a higher BMI and fasting blood glucose and a lower HDL-cholesterol level were more strongly associated with elevated hs-CRP rather than with SDB severity, suggesting that metabolic parameters are important contributors to cardiovascular diseases and should be corrected in patients with SDB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053

    PubMed  Google Scholar 

  2. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93

    Article  PubMed  Google Scholar 

  3. Somers VK, White DP, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American heart association/American college of cardiology foundation scientific statement from the American heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. J Am Coll Cardiol 52:686–717

    Article  PubMed  Google Scholar 

  4. Corrado E, Rizzo M, Coppola G et al (2010) An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 17:1–11

    Article  PubMed  CAS  Google Scholar 

  5. Ridker PM (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49:2129–2138

    Article  PubMed  CAS  Google Scholar 

  6. Peled N, Kassirer M, Shitrit D et al (2007) The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 101:1696–1701

    Article  PubMed  Google Scholar 

  7. Lee LA, Chen NH, Huang CG et al (2010) Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment. Otolaryngol Head Neck Surg 143:72–77

    Article  PubMed  Google Scholar 

  8. Saletu M, Nosiska D, Kapfhammer G et al (2006) Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol 253:746–752

    Article  PubMed  CAS  Google Scholar 

  9. Hu G, Qiao Q, Tuomilehto J (2005) The metabolic syndrome and cardiovascular risk. Curr Diabetes Rev 1:137–143

    Article  PubMed  Google Scholar 

  10. Ardern CI, Janssen I (2007) Metabolic syndrome and its association with morbidity and mortality. Appl Physiol Nutr Metab 32:33–45

    Article  PubMed  Google Scholar 

  11. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545

    PubMed  CAS  Google Scholar 

  12. Chen NH, Johns MW, Li HY et al (2002) Validation of a Chinese version of the Epworth sleepiness scale. Qual Life Res 11:817–821

    Article  PubMed  Google Scholar 

  13. Kushida CA, Littner MR, Morgenthaler T et al (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28:499–521

    PubMed  Google Scholar 

  14. Arnardottir ES, Mackiewicz M, Gislason T et al (2009) Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32:447–470

    PubMed  Google Scholar 

  15. Drager LF, Bortolotto LA, Krieger EM et al (2009) Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 53:64–69

    Article  PubMed  CAS  Google Scholar 

  16. Jelic S, Le Jemtel TH (2008) Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 18:253–260

    Article  PubMed  CAS  Google Scholar 

  17. Calhoun DA, Harding SM (2010) Sleep and hypertension. Chest 138:434–443

    Article  PubMed  Google Scholar 

  18. Sorajja D, Gami AS, Somers VK et al (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133:927–933

    Article  PubMed  Google Scholar 

  19. Yumino D, Wang H, Floras JS et al (2009) Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15:279–285

    Article  PubMed  Google Scholar 

  20. Arzt M, Young T, Finn L et al (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172:1447–1451

    Article  PubMed  Google Scholar 

  21. Lozano L, Tovar JL, Sampol G et al (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28:2161–2168

    PubMed  CAS  Google Scholar 

  22. de Lima AM, Franco CM, de Castro CM et al (2010) Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 79:370–376

    Article  PubMed  Google Scholar 

  23. Sharma SK, Mishra HK, Sharma H et al (2008) Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9:149–156

    Article  PubMed  CAS  Google Scholar 

  24. Ip MS, Lam B, Ng MM et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676

    PubMed  Google Scholar 

  25. Tan KC, Chow WS, Lam JC et al (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382

    Article  PubMed  CAS  Google Scholar 

  26. Savransky V, Nanayakkara A, Li J et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175:1290–1297

    Article  PubMed  CAS  Google Scholar 

  27. Trombetta IC, Somers VK, Maki-Nunes C et al (2010) Consequences of comorbid sleep apnea in the metabolic syndrome–implications for cardiovascular risk. Sleep 33:1193–1199

    PubMed  Google Scholar 

  28. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64:631–636

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Chang Gung Memorial Hospital (grant number: CMRPG870971). The authors would like to thank Richard H. Davis, English teacher, M.A., for professional editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hsin-Ching Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Su, MC., Chen, YC., Huang, KT. et al. Association of metabolic factors with high-sensitivity C-reactive protein in patients with sleep-disordered breathing. Eur Arch Otorhinolaryngol 270, 749–754 (2013). https://doi.org/10.1007/s00405-012-2191-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-012-2191-4

Keywords

Navigation